Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genuine Parts

124.54
-1.4800-1.17%
Post-market: 124.540.00000.00%18:27 EDT
Volume:896.09K
Turnover:111.42M
Market Cap:17.28B
PE:20.45
High:125.06
Open:124.78
Low:123.22
Close:126.02
Loading ...

Genuine Parts’s (NYSE:GPC) Q1: Beats On Revenue

StockStory
·
22 Apr

Genuine Parts: Q1 Earnings Snapshot

Associated Press Finance
·
22 Apr

Genuine Parts Q1 2025 Adj. EPS $1.75 Beats $1.68 Estimate, Sales $5.866B Beat $5.832B Estimate

Benzinga
·
22 Apr

BRIEF-Genuine Parts Q1 Adjusted EPS USD 1.75 Vs. IBES Estimate USD 1.68

Reuters
·
22 Apr

Genuine Parts Q1 EPS USD 1.4

THOMSON REUTERS
·
22 Apr

Genuine Parts: Outlook 2025 Does Not Include One-Time, Non-Cash Charge Company Expects to Record When Its U.S. Pension Plan Termination Settles

THOMSON REUTERS
·
22 Apr

Genuine Parts Co: Outlook 2025 Does Not Include Impacts From New U.S. Tariffs Announced in Q1 or Any Reciprocal Tariffs

THOMSON REUTERS
·
22 Apr

Genuine Parts Company Reports First Quarter 2025 Results and Reaffirms Full-Year Outlook

THOMSON REUTERS
·
22 Apr

Genuine Parts Company Reports First Quarter 2025 Results and Reaffirms Full-Year Outlook

PR Newswire
·
22 Apr

North American Morning Briefing: Stocks Poised For Rebound

Dow Jones
·
22 Apr

Genuine Parts Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
22 Apr

Genuine Parts (GPC) Q1 Earnings: What To Expect

StockStory
·
21 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
21 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
18 Apr

Genuine Parts Co. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
18 Apr

Loop Capital Markets Sticks to Their Buy Rating for Genuine Parts Company (GPC)

TIPRANKS
·
17 Apr

Is Genuine Parts Company (GPC) The Top Auto Parts Stock That Could Surge On Trump’s Auto Tariff Relaxation?

Insider Monkey
·
17 Apr

Genuine Parts Co. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
16 Apr

Exicure Close to Finishing Patient Recruitment in Phase 2 Study of GPC-100 in Multiple Myeloma

MT Newswires Live
·
15 Apr

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

Business Wire
·
15 Apr